EASTMAN CHEMICAL CO - Common Stock (EMN)

Historical Holders from Q1 2014 to Q4 2025

Symbol
EMN on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
114,272,546
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
100,371,048
Holdings value
$6,331,559,589
% of all portfolios
0.01%
Number of holders
651
Number of buys
278
Number of sells
414
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EASTMAN CHEMICAL CO - Common Stock (EMN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% $830,592,288 13,598,433 BlackRock, Inc. 30 Nov 2025
FRANKLIN RESOURCES INC 3.9% -24% $371,886,686 -$110,782,844 4,493,013 -23% Franklin Resources, Inc. 30 Jun 2025
Capital Research Global Investors 3.7% -28% $294,862,586 -$113,900,418 4,246,293 -28% Capital Research Global Investors 30 Jun 2025
As of 30 Sep 2025 EASTMAN CHEMICAL CO - Common Stock (EMN) has 651 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 100,371,048 shares of 114,272,546 outstanding shares and own 88% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of EASTMAN CHEMICAL CO - Common Stock (EMN) own 62% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
VANGUARD GROUP INC 13% $903,961,154 14,337,211 -2.2%
BlackRock, Inc. 7% $501,618,227 7,955,880 +0.95%
STATE STREET CORP 5% $363,313,637 5,687,097 +24%
Capital Research Global Investors 3.7% $265,112,892 4,204,804 -0.98%
DIMENSIONAL FUND ADVISORS LP 3.5% $255,515,254 4,052,656 +14%
MORGAN STANLEY 3.3% $241,261,303 3,826,505 -10%
FRANKLIN RESOURCES INC 3.2% $233,431,906 3,702,330 -18%
GEODE CAPITAL MANAGEMENT, LLC 2.7% $194,433,723 3,089,216 +4.5%
Invesco Ltd. 2.6% $185,218,823 2,937,650 -1.9%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.4% $174,723,530 2,771,190 -5.6%
EARNEST PARTNERS LLC 2% $140,915,048 2,234,973 -0.86%
Capital World Investors 1.6% $117,108,187 1,857,386 0%
BANK OF AMERICA CORP /DE/ 1.6% $116,824,078 1,852,880 -25%
LSV ASSET MANAGEMENT 1.1% $79,798,000 1,265,629 +5.3%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% $76,421,518 1,212,078 +2.8%
Bank of New York Mellon Corp 1% $74,768,354 1,185,858 -1.5%
NORTHERN TRUST CORP 1% $72,810,140 1,154,800 -5.3%
LETKO, BROSSEAU & ASSOCIATES INC 0.99% $71,402,297 1,132,471 +33%
Legal & General Group Plc 0.99% $70,987,303 1,125,889 -0.76%
CITADEL ADVISORS LLC 0.93% $66,706,648 1,057,996 +123%
SEI INVESTMENTS CO 0.85% $60,921,238 966,228 +10%
Allspring Global Investments Holdings, LLC 0.83% $58,488,691 943,975 +1011%
Empower Advisory Group, LLC 0.8% $57,396,168 910,328 +3.3%
Clearbridge Investments, LLC 0.78% $56,510,932 896,288 -25%
PNC Financial Services Group, Inc. 0.75% $54,108,181 858,179 -9.3%

Institutional Holders of EASTMAN CHEMICAL CO - Common Stock (EMN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 12,040 $768,405 -$425,626 $63.82 2
2025 Q3 100,371,048 $6,331,559,589 -$270,990,372 $63.05 651
2025 Q2 103,861,221 $7,759,070,049 -$55,461,675 $74.66 743
2025 Q1 104,335,251 $9,191,028,215 -$94,986,581 $88.11 795
2024 Q4 105,225,319 $9,611,810,799 +$411,988,580 $91.32 768
2024 Q3 99,557,066 $11,144,773,089 -$164,343,208 $111.95 774
2024 Q2 101,530,416 $9,946,897,672 +$304,161,024 $97.97 743
2024 Q1 98,729,602 $9,893,636,581 +$477,669,966 $100.22 739
2023 Q4 273,937 $24,605,224 -$4,282,337 $89.82 7
2023 Q3 92,080,755 $7,066,728,918 -$92,537,848 $76.72 658
2023 Q2 97,122,911 $8,135,238,530 -$130,735,716 $83.72 675
2023 Q1 99,465,273 $8,390,503,829 -$3,115,837 $84.34 676
2022 Q4 99,623,696 $8,121,862,323 -$141,295,402 $81.44 683
2022 Q3 99,349,281 $7,066,402,776 -$286,393,328 $71.05 627
2022 Q2 104,546,744 $9,384,039,525 -$210,524,196 $89.77 660
2022 Q1 107,706,319 $12,063,721,271 -$606,391,417 $112.06 730
2021 Q4 112,602,822 $13,606,012,137 -$42,549,975 $120.91 734
2021 Q3 112,757,103 $11,359,416,223 -$128,528,337 $100.74 691
2021 Q2 114,026,296 $13,303,929,481 -$109,862,066 $116.75 711
2021 Q1 115,010,861 $12,659,603,203 +$25,659,513 $110.12 717
2020 Q4 112,309,046 $11,259,355,814 +$127,820,039 $100.28 676
2020 Q3 114,702,461 $8,947,484,340 +$229,912,469 $78.12 616
2020 Q2 111,245,933 $7,748,393,156 +$316,198,484 $69.64 589
2020 Q1 102,906,318 $4,798,755,715 -$307,387,027 $46.58 549
2019 Q4 102,264,258 $8,105,271,614 +$172,000,968 $79.26 626
2019 Q3 109,481,007 $8,084,585,343 -$197,011,370 $73.83 604
2019 Q2 110,711,337 $8,612,263,099 +$67,931,120 $77.83 613
2019 Q1 108,291,162 $8,216,928,421 -$19,077,885 $75.88 675
2018 Q4 114,705,300 $8,374,507,455 -$243,228,974 $73.11 664
2018 Q3 111,791,056 $10,674,037,608 -$132,018,370 $95.72 680
2018 Q2 119,619,590 $11,932,345,062 +$32,795,879 $99.96 711
2018 Q1 121,361,891 $12,783,210,097 -$38,123,287 $105.58 685
2017 Q4 120,674,346 $11,163,734,899 +$148,188,754 $92.64 675
2017 Q3 120,910,689 $10,935,617,441 +$89,057,223 $90.49 610
2017 Q2 119,624,162 $10,045,318,176 +$20,268,819 $83.99 601
2017 Q1 119,320,414 $9,640,776,696 +$760,854,349 $80.80 590
2016 Q4 119,751,039 $9,005,252,845 -$164,163,901 $75.21 596
2016 Q3 121,816,310 $8,238,315,060 -$233,502,453 $67.68 549
2016 Q2 125,512,938 $8,522,312,624 -$37,845,645 $67.90 561
2016 Q1 126,005,487 $9,098,665,164 +$334,579,199 $72.23 555
2015 Q4 122,621,918 $8,278,374,263 -$6,582,875 $67.51 543
2015 Q3 123,186,456 $7,974,927,466 -$41,210,413 $64.72 551
2015 Q2 122,013,419 $9,981,461,148 +$267,311,976 $81.82 554
2015 Q1 121,221,336 $8,397,364,287 -$81,747,572 $69.26 548
2014 Q4 122,008,754 $9,255,810,675 +$103,095,519 $75.86 560
2014 Q3 119,366,235 $9,655,908,912 -$144,577,235 $80.89 525
2014 Q2 119,610,737 $10,447,218,691 -$146,943,345 $87.35 552
2014 Q1 122,213,090 $10,535,192,643 -$254,999,733 $86.21 539